Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 09 Dec 2025 for Vor Biopharma Inc..
Filing timeline
BuySaleSandesh Mahatme
Insider track record
Disclosed buys
0
Disclosed sells
9
Signal history
Sandesh Mahatme: trading record in brief
Sandesh Mahatme has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Sarepta Therapeutics, Inc., Vor Biopharma Inc. and Flexion Therapeutics Inc. Between 29 February 2016 and 5 December 2025, the trades on record add up to 69 filings.
No open-market purchase appears, only 9 sales worth €44.9M. Other entries cover 16 share grants and 38 option exercises.
The newest entry dates from 9 December 2025: a transaction, in Vor Biopharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sandesh Mahatme
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations69 total
694,137 shares0Common StockSEC:0001511034-25-000006:0
13,882,750 shares0Common StockSEC:0001415889-25-019640:0
2,385 shares@ US$13.7143.6% of flowCommon StockSEC:0001209191-20-042060:1
218 shares@ US$13.714.0% of flowCommon StockSEC:0001209191-20-042060:2
1,203 shares@ US$32.6352.4% of flowCommon StockSEC:0001209191-20-042060:3
20,425 shares0Common StockSEC:0001209191-20-042060:0
4,500 shares0Common StockSEC:0001209191-20-036257:0
6,700 shares0Common StockSEC:0001209191-20-014223:0
4,319 shares@ US$13.710.1% of flowCommon StockSEC:0001209191-19-061048:0
4,138 shares@ US$13.710.1% of flowCommon StockSEC:0001209191-19-061048:1
10,466 shares@ US$23.850.4% of flowCommon StockSEC:0001209191-19-061048:2
69,479 shares@ US$29.033.1% of flowCommon StockSEC:0001209191-19-061048:3
21,875 shares@ US$32.631.1% of flowCommon StockSEC:0001209191-19-061048:4
14,723 shares@ US$34.920.8% of flowCommon StockSEC:0001209191-19-061048:5
125,000 shares@ US$125.5024.1% of flowCommon StockSEC:0001209191-19-061048:6
42,535 shares0Common StockSEC:0001209191-19-047178:2
100,000 shares@ US$23.853.7% of flowCommon StockSEC:0001209191-19-047178:0
57,465 shares@ US$101.509.0% of flowCommon StockSEC:0001209191-19-047178:1
2,863 shares@ US$34.920.2% of flowCommon StockSEC:0001209191-19-046150:0
3,021 shares@ US$29.030.1% of flowCommon StockSEC:0001209191-19-046150:1
2,625 shares@ US$13.900.1% of flowCommon StockSEC:0001209191-19-046150:2
985 shares@ US$13.710.0% of flowCommon StockSEC:0001209191-19-046150:3
260 shares@ US$13.710.0% of flowCommon StockSEC:0001209191-19-046150:4
6,649 shares0Common StockSEC:0001209191-19-021878:0
2,953 shares@ US$118.680.5% of flowCommon StockSEC:0001209191-19-021878:1
25 of 69 declarations
